- Report
- September 2026
- 190 Pages
Global
From €3224EUR$3,545USD£2,771GBP
€3582EUR$3,939USD£3,079GBP
- Report
- September 2026
- 183 Pages
Global
From €3224EUR$3,545USD£2,771GBP
€3582EUR$3,939USD£3,079GBP
- Report
- February 2026
- 250 Pages
Global
From €4083EUR$4,490USD£3,510GBP
- Report
- April 2026
- 200 Pages
Global
From €2719EUR$2,990USD£2,337GBP
- Report
- September 2026
- 184 Pages
Global
From €3224EUR$3,545USD£2,771GBP
€3582EUR$3,939USD£3,079GBP
- Report
- September 2026
- 195 Pages
Global
From €3224EUR$3,545USD£2,771GBP
€3582EUR$3,939USD£3,079GBP
- Report
- September 2026
- 186 Pages
Global
From €3224EUR$3,545USD£2,771GBP
€3582EUR$3,939USD£3,079GBP
- Report
- September 2026
- 189 Pages
Global
From €5320EUR$5,850USD£4,573GBP
- Report
- February 2026
- 250 Pages
Global
From €4083EUR$4,490USD£3,510GBP
- Report
- February 2026
- 250 Pages
Global
From €4083EUR$4,490USD£3,510GBP
- Report
- September 2026
- 195 Pages
Global
From €3224EUR$3,545USD£2,771GBP
€3582EUR$3,939USD£3,079GBP
- Report
- September 2026
- 195 Pages
Global
From €3224EUR$3,545USD£2,771GBP
€3582EUR$3,939USD£3,079GBP
- Report
- January 2026
- 186 Pages
Global
From €4092EUR$4,500USD£3,518GBP
- Report
- September 2026
- 450 Pages
Global
From €4547EUR$5,000USD£3,909GBP
- Report
- May 2026
- 100 Pages
Global
From €2454EUR$2,699USD£2,110GBP
- Report
- April 2026
- 148 Pages
Global
From €2727EUR$2,999USD£2,345GBP
€3636EUR$3,999USD£3,126GBP
- Report
- October 2025
- 160 Pages
Global
From €2873EUR$3,160USD£2,470GBP
€3592EUR$3,950USD£3,088GBP
- Report
- November 2025
- 89 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- August 2026
- 200 Pages
United States
From €2264EUR$2,490USD£1,947GBP
- Report
- June 2025
- 110 Pages
United Kingdom
From €4501EUR$4,950USD£3,870GBP

Galantamine is a drug used to treat mild to moderate Alzheimer's Disease. It is an acetylcholinesterase inhibitor, meaning it works by increasing the amount of the neurotransmitter acetylcholine in the brain. This helps to improve memory, thinking, and behavior in people with Alzheimer's. Galantamine is available in both oral and intravenous forms, and is often used in combination with other Alzheimer's medications. It is generally well-tolerated, with the most common side effects being nausea, vomiting, and diarrhea.
Galantamine is one of several drugs used to treat Alzheimer's Disease, and is often prescribed alongside other medications such as donepezil and memantine. It is available in generic form, as well as under the brand names Razadyne and Reminyl.
Companies in the Galantamine market include Janssen Pharmaceuticals, Eisai Co., Ltd., and Shire Pharmaceuticals. Show Less Read more